肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

GAS5通过促进E-钙黏蛋白减弱胶质瘤干细胞样细胞的恶性进展

GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin 

原文发布日期:2022-12-02 

英文摘要:

摘要翻译: 

原文链接:

文章:

GAS5通过促进E-钙黏蛋白减弱胶质瘤干细胞样细胞的恶性进展

GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin 

原文发布日期:2022-12-02 

英文摘要:

It has been widely reported that glioma stem-like cells (GSCs) serve a crucial role in the malignant progression of glioma. In particular, recent studies have reported that long non-coding RNAs (lncRNAs) are closely associated with glioma development. However, the underlying molecular regulatory mechanistic role of GSCs remains poorly understood. The present study established two highly malignant glioma stem-like cell lines from clinical surgical specimens. In these, it was found that the lncRNA growth arrest-specific 5 (GAS5) expression was downregulated in GSCs and high-grade glioma tissues, compared with normal human astrocyte cells (NHAs) and normal brain tissues, respectively, which also showed a positive correlation with patient survival. Functional assays revealed that knocking down GAS5 expression promoted the proliferation, invasion, migration, stemness, and tumorigenicity of GSGs, while suppressing their apoptosis. Mechanistically, GAS5 directly sponged miR-23a, which in turn functioned as an oncogene by inhibiting E-cadherin, through the assays of reverse transcription-quantitative PCR (RT-qPCR) and luciferase reports. In addition, rescue experiments demonstrated that GAS5 could promote the expression and function of E-cadherin in a miR-23a-dependent manner. Collectively, these data suggest that GAS5 functions as a suppressor in GSCs by targeting the miR-23a/E-cadherin axis, which may be a promising therapeutic target against glioma. 

摘要翻译: 

已有广泛报道指出,胶质瘤干细胞样细胞(GSCs)在胶质瘤恶性进展中起关键作用。特别是近期研究表明,长链非编码RNA(lncRNA)与胶质瘤发展密切相关。然而,GSCs的分子调控机制仍未被充分阐明。本研究从临床手术标本中成功建立了两株高度恶性的胶质瘤干细胞样细胞系,发现与正常人星形胶质细胞(NHAs)和正常脑组织相比,lncRNA生长停滞特异性转录本5(GAS5)在GSCs和高级别胶质瘤组织中的表达均下调,且其表达水平与患者生存率呈正相关。功能实验表明,敲低GAS5表达可促进GSCs的增殖、侵袭、迁移、干性维持和成瘤能力,同时抑制细胞凋亡。通过逆转录定量PCR(RT-qPCR)和荧光素酶报告基因检测发现,GAS5可直接吸附miR-23a,而后者通过抑制E-钙黏蛋白发挥癌基因功能。此外,挽救实验证实GAS5能以miR-23a依赖性方式促进E-钙黏蛋白的表达和功能。综上所述,这些数据表明GAS5通过靶向miR-23a/E-钙黏蛋白轴在GSCs中发挥抑癌作用,该机制可能成为胶质瘤治疗的潜在靶点。

原文链接:

GAS5 attenuates the malignant progression of glioma stem-like cells by promoting E-cadherin

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……